Expression of ASCL2 in the breast cancer tissues and its influence on the prognosis

Yan Li,Hailin Lu,Min Tao,Tinghua Cao,Zhiqiang Ning,Zhipei Duan,Ying Tang,Lingling Wan

DOI: https://doi.org/10.3969/j.issn.1672-4992.2018.14.011

2018-01-01

Journal of Modern Oncology

Abstract:Objective:To detect the protein expression of the transcription factor achaete scute－like 2(ASCL2) in the breast cancer tissues,to determine the relationship between the protein expression of ASCL2 and the clinic-pathologic characteristics and to analyze the influence of ASCL2 expression on the prognosis.Methods:The immuno-histochemical SP method was used to detect the protein expression of the ASCL2 in 114 cases of breast cancer tissues and adjacent tissues.In addition,the relationship between the expression of ASCL2 and the clinicpathologic character-istics was analyzed.The relationship between ASCL2 protein expression and breast cancer patients'survival was detec-ted.The receiver operating characteristic(ROC)curves were analyzed to determine the sensitivity and specificity of the ASCL2 protein level in the prognosis of breast cancer.Results:The positive expression rates of ASCL2 protein in breast cancer tissues and adjacent tissues were 84.21%(96/114)and 0.88%(1/114),respectively(P＜0.05).In breast cancer tissues,the ASCL2 protein expression were related with the tumor diameter,lymph node metastasis status and the Ki67 index(P＜0.05),but not related with the age ,differentiation degree ,subtype and clinical stage (P＞0.05).The five－year survival rate in the ASCL2 protein－positive group was much shorter than that in the ASCL2 protein－negative group(P＝0.000).ROC analysis showed that the expression of ASCL2 protein was valuable for survival prediction of patients,the area under the ROC curve(AUC)was 0.925.Conclusion:The ASCL2 was highly expressed in breast cancer tissues,which was closely related with the malignancy and poor prognosis. ASCL2 may serve as a biomarker for the prognosis and the therapy of breast cancer.